Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 181
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 260502BDBM260502(US12629358, Compound C4)
Affinity DataIC50: 1.02nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808042BDBM808042(US12629358, Compound C17)
Affinity DataIC50: 1.26nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808043BDBM808043(US12629358, Compound C18)
Affinity DataIC50: 1.52nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808035BDBM808035(US12629358, Compound C8)
Affinity DataIC50: 1.53nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 260479BDBM260479(US12629358, Compound C2)
Affinity DataIC50: 1.98nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808040BDBM808040(US12629358, Compound C13)
Affinity DataIC50: 2.08nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 2579BDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 2.53nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808036BDBM808036(US12629358, Compound C9)
Affinity DataIC50: 3.38nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808033BDBM808033(US12629358, Compound C6)
Affinity DataIC50: 3.53nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808034BDBM808034(US12629358, Compound C7)
Affinity DataIC50: 5.34nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808039BDBM808039(US12629358, Compound C12)
Affinity DataIC50: 16.1nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808038BDBM808038(US12629358, Compound C11)
Affinity DataIC50: 17.4nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808044BDBM808044(US12629358, Compound C19)
Affinity DataIC50: 64.7nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808032BDBM808032(US12629358, Compound C5)
Affinity DataIC50: 100nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 260457BDBM260457(US12629358, Compound C1)
Affinity DataIC50: 146nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808041BDBM808041(US12629358, Compound C16)
Affinity DataIC50: 180nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 260483BDBM260483(US12629358, Compound C3)
Affinity DataIC50: 241nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Tyk Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 808037BDBM808037(US12629358, Compound C10)
Affinity DataIC50: 262nMAssay Description:Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/25/2018
Entry Details
US Patent